Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dianthus Therapeutics granted 60,000 stock options to three newly hired non-executive employees as material inducements to employment. The grants were approved by the Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4) and carry an exercise price of $89.45 per share.
Key figures
- Exercise price
- 89.45
- Shares granted
- 60000
- Grant term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.